Status:
RECRUITING
Adapting the FACETS Program to Sickle Cell Disease
Lead Sponsor:
Versailles Hospital
Collaborating Sponsors:
University Hospital, Grenoble
University Grenoble Alps
Conditions:
Fatigue Symptom
Sickle Cell Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Adaptation of a fatigue management program combining the principles of cognitive-behavioral therapy and energy conservation strategies (FACETS program) for a population of adult patients with sickle c...
Eligibility Criteria
Inclusion Criteria:
- Participant having freely given his oral agreement.
- Participant with a major sickle cell syndrome, regardless of genotype (e.g. SS, SC, Sbeta).
- Participant with a sufficient command of spoken and written French to take the assessments, complete the questionnaires, follow the program sessions and carry out the home exercises.
Exclusion Criteria:
- Participant with one or more severe psychiatric pathologies (e.g. severe depression, psychosis) that could interfere with the conduct of the study, in particular the primary and secondary endpoints.
- Participants with another chronic pathology causing fatigue.
- Participants in vaso-occlusive crisis (VOC) or hospitalization.
- Participant under legal protection (guardianship, curatorship, safeguard of justice, deprived of liberty).
Key Trial Info
Start Date :
January 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 2 2026
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT06650813
Start Date
January 10 2025
End Date
May 2 2026
Last Update
August 19 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Grenoble Alpes
Grenoble, France, 38000
2
Hospital Versailles
Le Chesnay, France, 78150